Rural Response to the Opioid Crisis – Resources
Selected recent or important resources focusing on Rural Response to the Opioid Crisis.
Introduction to Improving Telehealth and Virtual Care for Pain Management and Opioid/Substance Use Disorder
Summarizes a meeting of the Pain Management Guidelines and Evidence Standards (PM) and Prevention, Treatment, and Recovery Services (PTR) Working Groups of the National Academy of Medicine's Action Collaborative on Countering the U.S. Opioid Epidemic. Discusses telehealth flexibilities during the COVID-19 public health emergency, telehealth use for pain management, and telehealth-based treatment of opioid and substance use disorders.
Date: 06/2022
Sponsoring organization: National Academy of Medicine
view details
Summarizes a meeting of the Pain Management Guidelines and Evidence Standards (PM) and Prevention, Treatment, and Recovery Services (PTR) Working Groups of the National Academy of Medicine's Action Collaborative on Countering the U.S. Opioid Epidemic. Discusses telehealth flexibilities during the COVID-19 public health emergency, telehealth use for pain management, and telehealth-based treatment of opioid and substance use disorders.
Date: 06/2022
Sponsoring organization: National Academy of Medicine
view details
On the Farm
Documentary miniseries explores mental health and substance misuse on the American farm. Discusses the factors that contribute to psychological stress and substance use in farm families. Features interviews with experts as well as farmers and their families.
Additional links: Film Website
Date: 06/2022
Sponsoring organization: Mississippi State University
view details
Documentary miniseries explores mental health and substance misuse on the American farm. Discusses the factors that contribute to psychological stress and substance use in farm families. Features interviews with experts as well as farmers and their families.
Additional links: Film Website
Date: 06/2022
Sponsoring organization: Mississippi State University
view details
Characteristics of Adults Aged ≥18 Years Evaluated for Substance Use and Treatment Planning — United States, 2019
Examines past 30-day substance use patterns for alcohol, cannabis, cocaine, illicit stimulants, heroin, illicit fentanyl, prescription opioid misuse, prescription stimulant misuse, and prescription sedative, tranquilizer, and sleeping pill use. Also looks at the severity of problems experienced in these areas: alcohol, drug, employment, family, legal, medical, and psychiatric issues. Includes data for metropolitan, micropolitan, and rural areas.
Author(s): Akadia Kacha-Ochana, Christopher M. Jones, Jody L. Green, et al.
Citation: MMWR (Morbidity and Mortality Weekly Report), 71(23), 749-756
Date: 06/2022
Sponsoring organization: Centers for Disease Control and Prevention
view details
Examines past 30-day substance use patterns for alcohol, cannabis, cocaine, illicit stimulants, heroin, illicit fentanyl, prescription opioid misuse, prescription stimulant misuse, and prescription sedative, tranquilizer, and sleeping pill use. Also looks at the severity of problems experienced in these areas: alcohol, drug, employment, family, legal, medical, and psychiatric issues. Includes data for metropolitan, micropolitan, and rural areas.
Author(s): Akadia Kacha-Ochana, Christopher M. Jones, Jody L. Green, et al.
Citation: MMWR (Morbidity and Mortality Weekly Report), 71(23), 749-756
Date: 06/2022
Sponsoring organization: Centers for Disease Control and Prevention
view details
A Rural Community's Perspective on the Causes of and Solutions to the Opioid Crisis in Southern Virginia: A Qualitative Study
Results of a study to gain insight into the perceptions, knowledge, and experiences of members of a southern Virginia rural community affected by the opioid crisis, to inform the development of local strategies to address the problem. Examines barriers and facilitators to treatment programs and offers recommendations for targeting populations at risk.
Author(s): Angelina J. Hargrove, Carlin Rafie, Emily Zimmerman, Dawn E. Moser
Citation: Rural and Remote Health, 22(2), 7152
Date: 06/2022
view details
Results of a study to gain insight into the perceptions, knowledge, and experiences of members of a southern Virginia rural community affected by the opioid crisis, to inform the development of local strategies to address the problem. Examines barriers and facilitators to treatment programs and offers recommendations for targeting populations at risk.
Author(s): Angelina J. Hargrove, Carlin Rafie, Emily Zimmerman, Dawn E. Moser
Citation: Rural and Remote Health, 22(2), 7152
Date: 06/2022
view details
Expanded Naloxone Distribution to Reduce Rural Opioid Overdose Mortality
Discusses a study on the effect community-based and pharmacy-initiated naloxone distribution has had on rates of rural opioid overdose mortality. Highlights an intervention that expands naloxone access points in rural communities and pharmacies in addition to traditional provider-based treatment.
Date: 05/2022
Sponsoring organization: University of Vermont Center on Rural Addiction
view details
Discusses a study on the effect community-based and pharmacy-initiated naloxone distribution has had on rates of rural opioid overdose mortality. Highlights an intervention that expands naloxone access points in rural communities and pharmacies in addition to traditional provider-based treatment.
Date: 05/2022
Sponsoring organization: University of Vermont Center on Rural Addiction
view details
Assessment of Community-Level Vulnerability and Access to Medications for Opioid Use Disorder
Study examining access to medication for opioid use disorder (MOUD) in relation to social vulnerability to disasters based on zip code tabulation data (ZCTA) for 32,434 counties in the continental U.S. Discusses differences in geographic access to MOUD for rural and urban areas and the potential impacts of disasters on that access, highlighting potential interventions to bolster access to treatment.
Author(s): Paul J. Joudrey, Marynia Kolak, Qinyun Lin, et al.
Citation: JAMA Network Open, 5(4), e227028
Date: 04/2022
view details
Study examining access to medication for opioid use disorder (MOUD) in relation to social vulnerability to disasters based on zip code tabulation data (ZCTA) for 32,434 counties in the continental U.S. Discusses differences in geographic access to MOUD for rural and urban areas and the potential impacts of disasters on that access, highlighting potential interventions to bolster access to treatment.
Author(s): Paul J. Joudrey, Marynia Kolak, Qinyun Lin, et al.
Citation: JAMA Network Open, 5(4), e227028
Date: 04/2022
view details
Oversight: The Opioid Crisis in Tribal Communities
Recording of a U.S. House Natural Resources Committee, Subcommittee on Oversight and Investigations, hearing focused on the opioid crisis in tribal communities. Includes testimonies from representatives of the Cherokee Nation, the National Council of Urban Indian Health, the Border Patrol Council, and the Riverside-San Bernardino Indian Health.
Additional links: Art Del Cueto Testimony, Chuck Hoskin, Jr. Testimony, Maureen Rosette Testimony, Wayne Cortez Testimony, YouTube Recording
Date: 04/2022
Sponsoring organization: U.S. House of Representatives
view details
Recording of a U.S. House Natural Resources Committee, Subcommittee on Oversight and Investigations, hearing focused on the opioid crisis in tribal communities. Includes testimonies from representatives of the Cherokee Nation, the National Council of Urban Indian Health, the Border Patrol Council, and the Riverside-San Bernardino Indian Health.
Additional links: Art Del Cueto Testimony, Chuck Hoskin, Jr. Testimony, Maureen Rosette Testimony, Wayne Cortez Testimony, YouTube Recording
Date: 04/2022
Sponsoring organization: U.S. House of Representatives
view details
Impact of Telemedicine on Retention in Medications for Opioid Use Disorder (MOUD) Treatment with Buprenorphine in the Times of COVID-19 Pandemic: A Retrospective Chart Review
Study examining treatment retention for medication for opioid use disorder (MOUD) patients via telehealth during the COVID-19 pandemic, based on electronic health records of patients at a rural Federally Qualified Health Center (FQHC) in Pennsylvania. Discusses the impacts of telemedicine on retention rates, COVID-19-related challenges to treatment delivery systems, and policy measures to support telehealth and MOUD interventions.
Author(s): Jagdeep Kaur, Irakli Mania, Raghavendra Tirupathi, Lakshmi Polavarapu
Citation: Journal of Rural Mental Health, 46(2), 75-81
Date: 04/2022
view details
Study examining treatment retention for medication for opioid use disorder (MOUD) patients via telehealth during the COVID-19 pandemic, based on electronic health records of patients at a rural Federally Qualified Health Center (FQHC) in Pennsylvania. Discusses the impacts of telemedicine on retention rates, COVID-19-related challenges to treatment delivery systems, and policy measures to support telehealth and MOUD interventions.
Author(s): Jagdeep Kaur, Irakli Mania, Raghavendra Tirupathi, Lakshmi Polavarapu
Citation: Journal of Rural Mental Health, 46(2), 75-81
Date: 04/2022
view details
Strengthening Federal Mental Health and Substance Use Disorder Programs: Opportunities, Challenges, and Emerging Issues
Presents a full committee hearing of the U.S. Senate Committee on Health, Education, Labor, and Pensions discussing the current state of federal mental health and substance use disorder programs. Features testimonies from representatives of the Heath Resources and Services Administration, the Substance Abuse and Mental Health Services Administration, the National Institute of Mental Health, and the National Institute on Drug Abuse.
Additional links: Carole Johnson Testimony, Joshua A. Gordon Testimony, Miriam E. Delphin-Rittmon Testimony, Nora D. Volkow Testimony
Date: 03/2022
Sponsoring organization: Senate Committee on Health, Education, Labor & Pensions
view details
Presents a full committee hearing of the U.S. Senate Committee on Health, Education, Labor, and Pensions discussing the current state of federal mental health and substance use disorder programs. Features testimonies from representatives of the Heath Resources and Services Administration, the Substance Abuse and Mental Health Services Administration, the National Institute of Mental Health, and the National Institute on Drug Abuse.
Additional links: Carole Johnson Testimony, Joshua A. Gordon Testimony, Miriam E. Delphin-Rittmon Testimony, Nora D. Volkow Testimony
Date: 03/2022
Sponsoring organization: Senate Committee on Health, Education, Labor & Pensions
view details
Social Determinants of Mortality of COVID-19 and Opioid Overdose in American Rural and Urban Counties
Highlights a study on the social determinants of health that correlate with high COVID-19 and opioid overdose mortality in rural and urban counties. Breaks down county data by median income, unemployment, and healthcare workforce, among other factors.
Author(s): Yuhui Zhu, Zhe Fei, Larissa J. Mooney, et al.
Citation: Journal of Addiction Medicine, 16(1), e52-e55
Date: 02/2022
view details
Highlights a study on the social determinants of health that correlate with high COVID-19 and opioid overdose mortality in rural and urban counties. Breaks down county data by median income, unemployment, and healthcare workforce, among other factors.
Author(s): Yuhui Zhu, Zhe Fei, Larissa J. Mooney, et al.
Citation: Journal of Addiction Medicine, 16(1), e52-e55
Date: 02/2022
view details
Additional resources are available related to this guide. See the full list of resources by topic for:
Last Updated: 1/6/2025